* Sirtris was hoping to develop drugs that could treat diseases of aging‚ and in so doing had the potential to extend the lifespan of human beings. * The Sirtris team had‚ in fact‚ established a link between resveratrol‚ a compound found in red wine-producing grapes‚ and sirtuins‚ a newly discovered family of enzymes with links to improved longevity‚ metabolism and health in living things as diverse as yeast‚ mice and humans. Sinclair and Westphal were building Sirtris around the development
Premium Pharmacology Dietary supplement Nutrition
has been argued that the purpose of the merger was to serve as a method of consolidating Glaxo Wellcome ’s position in the pharmaceutical market‚ following competitive threats from generic products and reports of stifled profits. However‚ others have argued that the reason behind the merger was to facilitate the production of innovative pharmaceutical products; through strengthening the firm ’s core competences‚ given the lack of new products in the product pipeline. The aim of this report is to ascertain
Premium Pharmaceutical industry
British drug makers Glaxo Wellcome and SmithKline Beecham in December 2000‚ ranks as the world’s second largest pharmaceutical company. GSK group engaged in the creation‚ discovery‚ development‚ manufacture and marketing of pharmaceutical and consumer health-related products. GlaxoSmithKline supply one quarter of the world ’s vaccines and by the end of February 2008 GSK had 24 vaccines in clinical development. It has operations in some 114 countries‚ with products sold in over 140 countries. The company
Premium Pharmaceutical industry
COMPANY OVERVIEW GlaxoSmithKline (GSK) is one of the world’s leading research-based pharmaceutical and healthcare companies. The company is engaged in the discovery‚ development‚ manufacturing and marketing of pharmaceutical and consumer health-related products. The company primarily operates in 120 countries and its products are sold in more than 150 countries. GSK is headquartered in Brentford‚ the UK and employed 99‚913 people as of December 31‚ 2009. The company recorded revenues of £28‚368
Premium
EC229 Economics of Strategy Introduction 1. GlaxoSmithKline (GSK) is a global healthcare company specialized in the research‚ development‚ manufacturing and marketing of pharmaceutical and consumer health-related products. The company has operations in 120 countries‚ with products being sold in over 150 countries. (Description) 2. As a dominant player in the pharmaceutical industry‚ GSK operates in an oligopolistic market. It is highly cash generative‚ with increased sales growth and shareholder
Premium Costs Economics Oligopoly
history. This project looked at GlaxoSmithKline in Dungarvan‚ Co. Waterford. GSK has been manufacturing in Dungarvan since 1981 and has two manufacturing sites there. The first is the Oral care facility which was set up in 1981 and the second is the over the counter medicine site which was set up in 1987. Many of the company’s flagship brands are produced in Dungarvan including Panadol‚ Polygrip and NiQuitn. According to the GSK Website “Products produced in Dungarvan are exported to more than 70 countries
Premium
GlaxoSmithKline (GSK) is one of the largest and most profitable pharmaceutical companies in the world. This conglomerate is the product of multiple mergers of some of the leading companies in the industry. It was created in 2000 and at the time this case was written‚ had a market capitalization of $193.5 billion. The company’s most recent focus is on emerging markets‚ vaccines and consumer healthcare. When Sir Andrew Witty took over as CEO in 2008‚ he implemented a significant restructuring program
Premium Vaccine Pharmacology Pharmaceutical industry
Introduction Based on a report conducted by a pharmaceutical magazine‚ Glaxosmithkline plc (Also known as GSK) is the fifth largest pharmaceutical company around the world (Contract Pharma‚ 2013). And it is also tided at No.112 on the 2013 ’s Global 2000 list‚ the list that manifests the 2000 most enormous companies in the world (Forbes‚ 2013). The researches above have indicated that GSK is one of the largest Transnational Corporation in the world. Top 10 Pharmaceutical Companies based on 2012
Premium Strategic management Pharmaceutical industry
Recent Strategy‚ "It ’s important that we generate more growth with less risk." GSK needs to find new sources of growth at a time when governments around the world are reforming healthcare and cutting spending. It is also outsourcing more research to partners to reduce risk. Its long-running collaboration with the US company‚ Theravance which is responsible for one of GSK ’s most promising new drugs‚ the asthma treatment Relovair‚ which is now in late-stage development. GSK recently upped its stake
Premium Clinical trial Strategic management Pharmacology
GSK Marketing Planning | March 31 2013 | Calvin Cheung‚ Hussain Al Katib‚ Manpreet Budwal‚ Sandra Okechukwu | SOSTAC Review based on GlaxoSmithKline | Content Table of Contents 1.0 Introduction2 2.0 Situation Analysis3 2.1 PESTEL Analysis3 2.2 SWOT Analysis4 2.3 Boston Matrix5 2.4 Porter’s Five Forces Analysis6 3.0 Objectives8 4.0 Strategy9 4.1 Product9 4.2 Price9 4.3 Promotion9 4.4 Place10 4.5 Person10 4.6 Process10 4.7 Physical Evidence10 5.0 Tactics11 6.0 Action Plan12
Premium Marketing